Structure

Physi-Chem Properties

Molecular Weight:  476.15
Volume:  480.007
LogP:  3.617
LogD:  3.238
LogS:  -3.565
# Rotatable Bonds:  9
TPSA:  111.52
# H-Bond Aceptor:  8
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.28
Synthetic Accessibility Score:  3.529
Fsp3:  0.185
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.924
MDCK Permeability:  1.0243614269711543e-05
Pgp-inhibitor:  0.301
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.017
20% Bioavailability (F20%):  0.004
30% Bioavailability (F30%):  0.009

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.023
Plasma Protein Binding (PPB):  100.041015625%
Volume Distribution (VD):  0.409
Pgp-substrate:  1.829384684562683%

ADMET: Metabolism

CYP1A2-inhibitor:  0.222
CYP1A2-substrate:  0.83
CYP2C19-inhibitor:  0.886
CYP2C19-substrate:  0.068
CYP2C9-inhibitor:  0.891
CYP2C9-substrate:  0.958
CYP2D6-inhibitor:  0.397
CYP2D6-substrate:  0.879
CYP3A4-inhibitor:  0.779
CYP3A4-substrate:  0.661

ADMET: Excretion

Clearance (CL):  4.688
Half-life (T1/2):  0.697

ADMET: Toxicity

hERG Blockers:  0.161
Human Hepatotoxicity (H-HT):  0.044
Drug-inuced Liver Injury (DILI):  0.297
AMES Toxicity:  0.213
Rat Oral Acute Toxicity:  0.174
Maximum Recommended Daily Dose:  0.705
Skin Sensitization:  0.915
Carcinogencity:  0.724
Eye Corrosion:  0.003
Eye Irritation:  0.487
Respiratory Toxicity:  0.147

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC469889

Natural Product ID:  NPC469889
Common Name*:   2,3-Dihydro-2-(4'-Hydroxy-3'-Methoxyphenyl)-3-P-Hydroxybenzoyloxymethyl-5-(2-Formylvinyl)-7-Methoxybenzofuran
IUPAC Name:   [2-(4-hydroxy-3-methoxyphenyl)-7-methoxy-5-[(E)-3-oxoprop-1-enyl]-2,3-dihydro-1-benzofuran-3-yl]methyl 4-hydroxybenzoate
Synonyms:  
Standard InCHIKey:  JRDSHOZYAFZUGI-ONEGZZNKSA-N
Standard InCHI:  InChI=1S/C27H24O8/c1-32-23-14-18(7-10-22(23)30)25-21(15-34-27(31)17-5-8-19(29)9-6-17)20-12-16(4-3-11-28)13-24(33-2)26(20)35-25/h3-14,21,25,29-30H,15H2,1-2H3/b4-3+
SMILES:  COC1=CC(=CC2=C1OC(C2COC(=O)C3=CC=C(C=C3)O)C4=CC(=C(C=C4)O)OC)C=CC=O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1224885
PubChem CID:   49866360
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003405] 2-arylbenzofuran flavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32697 calamus quiquesetinervius Species n.a. n.a. n.a. n.a. n.a. PMID[20056545]
NPO32697 calamus quiquesetinervius Species n.a. n.a. n.a. n.a. n.a. PMID[20825224]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT113 Cell Line RAW264.7 Mus musculus Activity > 90.0 % PMID[493241]
NPT113 Cell Line RAW264.7 Mus musculus IC50 = 69000.0 nM PMID[493241]
NPT1 Others Radical scavenging activity IC50 > 100000.0 nM PMID[493241]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 19100.0 nM PMID[493241]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 200000.0 nM PMID[493241]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC469889 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9615 High Similarity NPC45943
0.9487 High Similarity NPC216916
0.9474 High Similarity NPC267091
0.9416 High Similarity NPC180901
0.9416 High Similarity NPC300757
0.9412 High Similarity NPC131121
0.9408 High Similarity NPC243891
0.9371 High Similarity NPC43065
0.9317 High Similarity NPC180768
0.9211 High Similarity NPC236166
0.9202 High Similarity NPC316539
0.9125 High Similarity NPC272750
0.9125 High Similarity NPC223006
0.9125 High Similarity NPC134047
0.9125 High Similarity NPC173729
0.9062 High Similarity NPC144557
0.9057 High Similarity NPC472961
0.9057 High Similarity NPC472962
0.9057 High Similarity NPC53889
0.8994 High Similarity NPC87317
0.8981 High Similarity NPC469888
0.8961 High Similarity NPC472969
0.8931 High Similarity NPC114179
0.8931 High Similarity NPC156818
0.8931 High Similarity NPC160512
0.8931 High Similarity NPC68324
0.8931 High Similarity NPC289322
0.8931 High Similarity NPC143328
0.8931 High Similarity NPC38779
0.8917 High Similarity NPC115203
0.8903 High Similarity NPC98809
0.8903 High Similarity NPC476394
0.8889 High Similarity NPC163898
0.8882 High Similarity NPC92589
0.8868 High Similarity NPC88803
0.8868 High Similarity NPC300845
0.8868 High Similarity NPC250436
0.8868 High Similarity NPC104983
0.8868 High Similarity NPC165483
0.8868 High Similarity NPC291948
0.8854 High Similarity NPC476434
0.8848 High Similarity NPC131866
0.8848 High Similarity NPC102277
0.8848 High Similarity NPC279209
0.8831 High Similarity NPC287495
0.8831 High Similarity NPC9370
0.8827 High Similarity NPC476372
0.8827 High Similarity NPC476371
0.8824 High Similarity NPC284881
0.8824 High Similarity NPC93433
0.8824 High Similarity NPC474444
0.8824 High Similarity NPC264706
0.882 High Similarity NPC292415
0.882 High Similarity NPC24164
0.8816 High Similarity NPC67467
0.8816 High Similarity NPC131971
0.8812 High Similarity NPC35598
0.8812 High Similarity NPC222689
0.8797 High Similarity NPC474656
0.8797 High Similarity NPC470769
0.8795 High Similarity NPC247964
0.8788 High Similarity NPC41494
0.8788 High Similarity NPC186100
0.8788 High Similarity NPC216403
0.878 High Similarity NPC472452
0.8766 High Similarity NPC213900
0.8766 High Similarity NPC275278
0.8765 High Similarity NPC109061
0.8765 High Similarity NPC103201
0.8765 High Similarity NPC473106
0.8765 High Similarity NPC478267
0.875 High Similarity NPC67629
0.875 High Similarity NPC79736
0.875 High Similarity NPC318432
0.8743 High Similarity NPC98583
0.8742 High Similarity NPC62051
0.8734 High Similarity NPC124842
0.8734 High Similarity NPC75695
0.8727 High Similarity NPC311912
0.872 High Similarity NPC471788
0.872 High Similarity NPC472277
0.872 High Similarity NPC142614
0.8712 High Similarity NPC476247
0.8712 High Similarity NPC42797
0.8712 High Similarity NPC472635
0.8712 High Similarity NPC473445
0.8712 High Similarity NPC144843
0.8704 High Similarity NPC476373
0.8704 High Similarity NPC21046
0.8704 High Similarity NPC328102
0.8704 High Similarity NPC472624
0.8701 High Similarity NPC473090
0.8698 High Similarity NPC267549
0.8696 High Similarity NPC296044
0.8696 High Similarity NPC125495
0.8696 High Similarity NPC133984
0.8696 High Similarity NPC167098
0.8696 High Similarity NPC291508
0.869 High Similarity NPC193377
0.8688 High Similarity NPC268008
0.8683 High Similarity NPC100251
0.8683 High Similarity NPC65333
0.8679 High Similarity NPC295646
0.8679 High Similarity NPC199773
0.8675 High Similarity NPC88557
0.8667 High Similarity NPC207575
0.8667 High Similarity NPC255787
0.8667 High Similarity NPC13481
0.8667 High Similarity NPC235610
0.8659 High Similarity NPC18100
0.8659 High Similarity NPC124038
0.8659 High Similarity NPC291977
0.8659 High Similarity NPC472281
0.8659 High Similarity NPC205265
0.8659 High Similarity NPC89131
0.865 High Similarity NPC142252
0.865 High Similarity NPC124747
0.865 High Similarity NPC349525
0.865 High Similarity NPC155754
0.8645 High Similarity NPC113397
0.8642 High Similarity NPC94220
0.8642 High Similarity NPC166456
0.8642 High Similarity NPC7543
0.8642 High Similarity NPC98083
0.8642 High Similarity NPC24339
0.8642 High Similarity NPC478269
0.8634 High Similarity NPC195796
0.8634 High Similarity NPC228357
0.8634 High Similarity NPC291878
0.8634 High Similarity NPC35038
0.8634 High Similarity NPC471405
0.8634 High Similarity NPC278778
0.8627 High Similarity NPC326065
0.8625 High Similarity NPC194095
0.8625 High Similarity NPC191046
0.8625 High Similarity NPC327032
0.8623 High Similarity NPC476365
0.8623 High Similarity NPC52598
0.8614 High Similarity NPC186392
0.8614 High Similarity NPC473818
0.8608 High Similarity NPC473091
0.8608 High Similarity NPC261322
0.8606 High Similarity NPC108433
0.8606 High Similarity NPC300053
0.8606 High Similarity NPC41689
0.8599 High Similarity NPC473408
0.8598 High Similarity NPC81679
0.8598 High Similarity NPC249070
0.8596 High Similarity NPC475996
0.8596 High Similarity NPC53680
0.8596 High Similarity NPC208797
0.8589 High Similarity NPC476283
0.8589 High Similarity NPC36217
0.8589 High Similarity NPC47623
0.8589 High Similarity NPC24627
0.8581 High Similarity NPC50954
0.8581 High Similarity NPC160378
0.858 High Similarity NPC226759
0.858 High Similarity NPC474055
0.858 High Similarity NPC472598
0.858 High Similarity NPC470827
0.858 High Similarity NPC108456
0.858 High Similarity NPC299520
0.858 High Similarity NPC129684
0.858 High Similarity NPC27337
0.8571 High Similarity NPC10205
0.8571 High Similarity NPC470327
0.8571 High Similarity NPC477503
0.8571 High Similarity NPC80489
0.8571 High Similarity NPC203757
0.8571 High Similarity NPC271848
0.8571 High Similarity NPC81332
0.8571 High Similarity NPC262580
0.8571 High Similarity NPC289396
0.8571 High Similarity NPC200761
0.8571 High Similarity NPC45849
0.8571 High Similarity NPC212038
0.8563 High Similarity NPC288813
0.8563 High Similarity NPC202428
0.8563 High Similarity NPC266545
0.8563 High Similarity NPC476279
0.8562 High Similarity NPC157898
0.8562 High Similarity NPC3744
0.8562 High Similarity NPC137125
0.8554 High Similarity NPC263212
0.8554 High Similarity NPC291742
0.8554 High Similarity NPC119589
0.8553 High Similarity NPC300329
0.8545 High Similarity NPC100425
0.8545 High Similarity NPC308156
0.8545 High Similarity NPC100420
0.8544 High Similarity NPC107636
0.8537 High Similarity NPC266314
0.8537 High Similarity NPC26326
0.8537 High Similarity NPC471499
0.8537 High Similarity NPC131905
0.8537 High Similarity NPC472634
0.8537 High Similarity NPC112418
0.8537 High Similarity NPC158188
0.8535 High Similarity NPC39361

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC469889 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8868 High Similarity NPD4868 Clinical (unspecified phase)
0.8563 High Similarity NPD5844 Phase 1
0.8509 High Similarity NPD2393 Clinical (unspecified phase)
0.8447 Intermediate Similarity NPD1934 Approved
0.8393 Intermediate Similarity NPD3818 Discontinued
0.8387 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.8383 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8383 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8383 Intermediate Similarity NPD6166 Phase 2
0.8373 Intermediate Similarity NPD6232 Discontinued
0.8333 Intermediate Similarity NPD7473 Discontinued
0.8293 Intermediate Similarity NPD3882 Suspended
0.8291 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.8253 Intermediate Similarity NPD5494 Approved
0.8246 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8242 Intermediate Similarity NPD7075 Discontinued
0.8232 Intermediate Similarity NPD3817 Phase 2
0.8218 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.8217 Intermediate Similarity NPD4628 Phase 3
0.8204 Intermediate Similarity NPD7199 Phase 2
0.8198 Intermediate Similarity NPD6559 Discontinued
0.8193 Intermediate Similarity NPD6234 Discontinued
0.8171 Intermediate Similarity NPD2801 Approved
0.8171 Intermediate Similarity NPD1465 Phase 2
0.8137 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.8107 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.8081 Intermediate Similarity NPD7074 Phase 3
0.8079 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8061 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8061 Intermediate Similarity NPD7819 Suspended
0.8049 Intermediate Similarity NPD7411 Suspended
0.8023 Intermediate Similarity NPD7054 Approved
0.8012 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD37 Approved
0.8 Intermediate Similarity NPD6801 Discontinued
0.7989 Intermediate Similarity NPD7685 Pre-registration
0.7988 Intermediate Similarity NPD4380 Phase 2
0.7977 Intermediate Similarity NPD7472 Approved
0.7976 Intermediate Similarity NPD919 Approved
0.7964 Intermediate Similarity NPD4966 Approved
0.7964 Intermediate Similarity NPD4965 Approved
0.7964 Intermediate Similarity NPD4967 Phase 2
0.795 Intermediate Similarity NPD1511 Approved
0.7943 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7937 Intermediate Similarity NPD6190 Approved
0.7911 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7901 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7882 Intermediate Similarity NPD8127 Discontinued
0.7865 Intermediate Similarity NPD8434 Phase 2
0.7861 Intermediate Similarity NPD7228 Approved
0.7857 Intermediate Similarity NPD7768 Phase 2
0.7853 Intermediate Similarity NPD1512 Approved
0.7849 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7848 Intermediate Similarity NPD2935 Discontinued
0.7829 Intermediate Similarity NPD6797 Phase 2
0.7818 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7818 Intermediate Similarity NPD3226 Approved
0.7811 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7797 Intermediate Similarity NPD8312 Approved
0.7797 Intermediate Similarity NPD8313 Approved
0.7791 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7791 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7784 Intermediate Similarity NPD7251 Discontinued
0.7778 Intermediate Similarity NPD9494 Approved
0.7778 Intermediate Similarity NPD6959 Discontinued
0.7742 Intermediate Similarity NPD6798 Discontinued
0.774 Intermediate Similarity NPD7808 Phase 3
0.7738 Intermediate Similarity NPD8455 Phase 2
0.773 Intermediate Similarity NPD6799 Approved
0.7711 Intermediate Similarity NPD7458 Discontinued
0.7707 Intermediate Similarity NPD6355 Discontinued
0.7707 Intermediate Similarity NPD230 Phase 1
0.7683 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7683 Intermediate Similarity NPD2534 Approved
0.7683 Intermediate Similarity NPD2532 Approved
0.7683 Intermediate Similarity NPD2533 Approved
0.7674 Intermediate Similarity NPD1247 Approved
0.7673 Intermediate Similarity NPD2799 Discontinued
0.7665 Intermediate Similarity NPD6599 Discontinued
0.7654 Intermediate Similarity NPD3750 Approved
0.7643 Intermediate Similarity NPD4060 Phase 1
0.764 Intermediate Similarity NPD1549 Phase 2
0.7636 Intermediate Similarity NPD6273 Approved
0.763 Intermediate Similarity NPD7229 Phase 3
0.7628 Intermediate Similarity NPD3764 Approved
0.7614 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7602 Intermediate Similarity NPD3749 Approved
0.7595 Intermediate Similarity NPD447 Suspended
0.759 Intermediate Similarity NPD920 Approved
0.7588 Intermediate Similarity NPD5402 Approved
0.7586 Intermediate Similarity NPD3926 Phase 2
0.758 Intermediate Similarity NPD6233 Phase 2
0.7578 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7578 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7566 Intermediate Similarity NPD1608 Approved
0.7546 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7546 Intermediate Similarity NPD4110 Phase 3
0.7546 Intermediate Similarity NPD7003 Approved
0.7545 Intermediate Similarity NPD1653 Approved
0.7532 Intermediate Similarity NPD1613 Approved
0.7532 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7531 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD1551 Phase 2
0.7516 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD2796 Approved
0.75 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7486 Intermediate Similarity NPD7038 Approved
0.7486 Intermediate Similarity NPD7039 Approved
0.7485 Intermediate Similarity NPD5403 Approved
0.747 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7469 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7469 Intermediate Similarity NPD6002 Phase 3
0.7469 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7469 Intermediate Similarity NPD7266 Discontinued
0.7469 Intermediate Similarity NPD2344 Approved
0.7469 Intermediate Similarity NPD2346 Discontinued
0.7469 Intermediate Similarity NPD6004 Phase 3
0.7469 Intermediate Similarity NPD6005 Phase 3
0.7458 Intermediate Similarity NPD7177 Discontinued
0.7455 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7453 Intermediate Similarity NPD7033 Discontinued
0.7453 Intermediate Similarity NPD1510 Phase 2
0.7452 Intermediate Similarity NPD3027 Phase 3
0.7439 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7439 Intermediate Similarity NPD8166 Discontinued
0.7419 Intermediate Similarity NPD2797 Approved
0.7412 Intermediate Similarity NPD6386 Approved
0.7412 Intermediate Similarity NPD6385 Approved
0.7405 Intermediate Similarity NPD3268 Approved
0.7405 Intermediate Similarity NPD2313 Discontinued
0.7405 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD7240 Approved
0.7377 Intermediate Similarity NPD8150 Discontinued
0.7375 Intermediate Similarity NPD1933 Approved
0.7368 Intermediate Similarity NPD17 Approved
0.7365 Intermediate Similarity NPD5401 Approved
0.7346 Intermediate Similarity NPD3748 Approved
0.7326 Intermediate Similarity NPD5760 Phase 2
0.7326 Intermediate Similarity NPD5761 Phase 2
0.7325 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7325 Intermediate Similarity NPD2861 Phase 2
0.7312 Intermediate Similarity NPD1240 Approved
0.7301 Intermediate Similarity NPD2438 Suspended
0.7289 Intermediate Similarity NPD2309 Approved
0.7288 Intermediate Similarity NPD5242 Approved
0.7278 Intermediate Similarity NPD6832 Phase 2
0.7278 Intermediate Similarity NPD4908 Phase 1
0.7273 Intermediate Similarity NPD6674 Discontinued
0.7273 Intermediate Similarity NPD1243 Approved
0.7273 Intermediate Similarity NPD2800 Approved
0.7249 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7239 Intermediate Similarity NPD4308 Phase 3
0.7238 Intermediate Similarity NPD5953 Discontinued
0.7237 Intermediate Similarity NPD9545 Approved
0.7233 Intermediate Similarity NPD7095 Approved
0.7222 Intermediate Similarity NPD1607 Approved
0.7209 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7205 Intermediate Similarity NPD943 Approved
0.7198 Intermediate Similarity NPD6765 Approved
0.7198 Intermediate Similarity NPD6764 Approved
0.7197 Intermediate Similarity NPD1203 Approved
0.7195 Intermediate Similarity NPD5408 Approved
0.7195 Intermediate Similarity NPD5404 Approved
0.7195 Intermediate Similarity NPD5406 Approved
0.7195 Intermediate Similarity NPD5405 Approved
0.7193 Intermediate Similarity NPD3455 Phase 2
0.7184 Intermediate Similarity NPD5353 Approved
0.7178 Intermediate Similarity NPD7097 Phase 1
0.7174 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7167 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7167 Intermediate Similarity NPD3751 Discontinued
0.716 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7158 Intermediate Similarity NPD7549 Discontinued
0.7158 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD5762 Approved
0.7152 Intermediate Similarity NPD5763 Approved
0.7143 Intermediate Similarity NPD7440 Discontinued
0.7135 Intermediate Similarity NPD5711 Approved
0.7135 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD5710 Approved
0.7134 Intermediate Similarity NPD1283 Approved
0.7127 Intermediate Similarity NPD7286 Phase 2
0.7121 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7121 Intermediate Similarity NPD7783 Phase 2
0.7118 Intermediate Similarity NPD5049 Phase 3
0.7117 Intermediate Similarity NPD6653 Approved
0.7113 Intermediate Similarity NPD7680 Approved
0.7113 Intermediate Similarity NPD7435 Discontinued
0.711 Intermediate Similarity NPD6873 Phase 2
0.7107 Intermediate Similarity NPD8151 Discontinued
0.7099 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7099 Intermediate Similarity NPD2979 Phase 3
0.7099 Intermediate Similarity NPD3620 Phase 2
0.7091 Intermediate Similarity NPD6100 Approved
0.7091 Intermediate Similarity NPD4476 Approved
0.7091 Intermediate Similarity NPD4477 Approved
0.7091 Intermediate Similarity NPD6099 Approved
0.7089 Intermediate Similarity NPD3266 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data